Delivery Order SPE2DB20D7061-SPE2DB25FSMP5
Award Date
3/21/25
Potential Completion Date
3/24/25
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,534.92, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. The contract was not set aside for any specific business type. AmerisourceBergen also holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,976.49, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medical product. It is a Firm Fixed Price Delivery Order contract, with a period of performance through February 7, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,187.73, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,637.56, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 6, 2025. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,782.05, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of January 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,392.11, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medical product. It is a firm fixed price delivery order contract with an ultimate completion date of April 1, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
This federal contract award, valued at $7,422.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a period of performance through February 25, 2025. The contract was not designated with a set-aside requirement, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,036.07, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medication. It is a firm fixed-price delivery order contract with a completion date of March 12, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,308.78, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of March 13, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.50, is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of March 25, 2025. The contract is not designated as a Set-Aside and was awarded on March 24, 2025....